MARKET

KDMN

KDMN

KADMON
NYSE

Real-time Quotes | Nasdaq Last Sale

4.470
-0.010
-0.22%
After Hours: 4.470 0 0.00% 16:00 01/24 EST
OPEN
4.480
PREV CLOSE
4.480
HIGH
4.640
LOW
4.400
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
5.38
52 WEEK LOW
1.630
MARKET CAP
713.12M
P/E (TTM)
-5.3862
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of KDMN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

KDMN News

  • Benzinga's Top Upgrades, Downgrades For January 23, 2020
  • Benzinga.2d ago
  • 3 Healthcare Stocks With Important Catalysts in Q1
  • TipRanks.3d ago
  • Kadmon to present KD025 data at TCT; shares +2.2%
  • seekingalpha.01/11 04:06
  • Kadmon Announces Acceptance of Late-Breaking Abstract of KD025 for cGVHD at the 2020 TCT Meetings
  • ACCESSWIRE.01/10 21:15

More

Industry

Pharmaceuticals
-1.84%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About KDMN

Kadmon Holdings, Inc. is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir. KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. Tesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. KD034 is the Company's portfolio of enhanced formulations of trientine hydrochloride for the treatment of Wilson's disease.
More

Webull offers Kadmon Holdings Inc (KDMN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.